Bill Gates giving $50 million for Alzheimer's research

November 13, 2017

Microsoft co-founder Bill Gates announced Monday that he is investing $50 million to fund research into treatment for Alzheimer's disease.

Gates, in an entry on his blog, said he was making the investment from his personal fortune and not with his charitable Bill & Melinda Gates Foundation.

"Of all the disorders that plague us late in life, one stands out as a particularly big threat to society: Alzheimer's disease," Gates said.

"Scientists have yet to figure out what exactly causes Alzheimer's or how to stop the disease from destroying the brain," he said. "In the United States, it is the only cause of death in the top 10 without any meaningful treatments."

Gates said he was investing $50 million in the London-based Dementia Discovery Fund, a private-public venture that supports innovative research into dementia.

The multi-billionaire philanthropist said finding for Alzheimer's, which affects nearly 50 million people worldwide, was particularly urgent since improved medical care meant people were living longer.

He noted that his own father would soon celebrate his 92nd birthday—"a milestone that was practically unimaginable when he was born."

Gates said there is a nearly 50 percent chance of developing Alzheimer's for people who live into their mid-80s.

"If you get the in your 60s or 70s, you might require expensive care for decades," he said.

"Absent a major breakthrough, expenditures will continue to squeeze healthcare budgets in the years and decades to come," Gates said.

Gates acknowledged that making progress against Alzheimer's would be a long-term project.

"The first Alzheimer's treatments might not come to fruition for another decade or more, and they will be very expensive at first," he said.

"Once that day comes, our foundation might look at how we can expand access in ," he said.

But Gates said he was optimistic.

"We've seen scientific innovation turn once-guaranteed killers like HIV into chronic illnesses that can be held in check with medication," he said. "I believe we can do the same (or better) with Alzheimer's."

The Bill & Melinda Gates Foundation has concentrated mainly on fighting communicable diseases such as malaria and polio in poor countries.

Explore further: Bill Gates hopeful of AIDS vaccine in 10 years

Related Stories

Bill Gates hopeful of AIDS vaccine in 10 years

June 26, 2015
Billionaire and philanthropist Bill Gates, who spends millions of dollars on AIDS drug development, said Friday he hoped for a vaccine against the disease within the next decade as a cure remains far off.

Recommended for you

Pregnancy history may be tied to Alzheimer's disease

July 18, 2018
A woman's history of pregnancy may affect her risk of Alzheimer's disease decades later, according to a study published in the July 18, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. ...

Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

July 17, 2018
In a small study of military personnel who had suffered head trauma and had reported memory and mood problems, UCLA researchers found brain changes similar to those seen in retired football players with suspected chronic ...

Yale-developed test for Alzheimer's disease directly measures synaptic loss

July 16, 2018
Yale researchers have tested a new method for directly measuring synaptic loss in individuals with Alzheimer's disease. The method, which uses PET imaging technology to scan for a specific protein in the brain linked to synapses, ...

New study highlights Alzheimer's herpes link, experts say

July 12, 2018
A new commentary by scientists at the Universities of Manchester and Edinburgh on a study by Taiwanese epidemiologists supports the viability of a potential way to reduce the risk of Alzheimer's disease.

Practice imperfect—repeated cognitive testing can obscure early signs of dementia

July 12, 2018
Alzheimer's disease (AD) is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

The 'Big Bang' of Alzheimer's: Scientists ID genesis of disease, focus efforts on shape-shifting tau

July 10, 2018
Scientists have discovered a "Big Bang" of Alzheimer's disease – the precise point at which a healthy protein becomes toxic but has not yet formed deadly tangles in the brain.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.